Shopping Cart 0
Cart Subtotal
USD 0

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

Bundle Purchase

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 4000

Access to Printed Report; No Soft Copy
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : Printed Publication/ Book by Post

Hard Copy License
USD 4000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 6000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

CD-Rom
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8000

Details

This report describes and evaluates the animal testing and non-alternative testing market in major geographies.

Animal testing or experiment on animals done in the early stages of drug development and for toxicity and safety assessment of medical devices, chemicals, pesticides, cosmetics, and food compounds. Animal experiments are necessary before testing on humans mainly to evaluate toxicity, pharmacokinetics, and safety of a drug or a chemical. However, there is an increasing pressure from the animal welfare organizations on governmental agencies and companies to use non-animal alternative testing technologies. These technologies include in-vitro cell and tissue cultures, organ-on-chip, computer simulations, 3D bio printing of tissues, and synthetic skin substitutes, among others. Industries such as pharmaceuticals, medical devices, chemicals & pesticides and food are increasingly adopting these technologies to replace animal testing.

Animal Testing

The global animal testing market was valued at USD 10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. USA and Japan are the major animal testing markets in the world.The USA's animal testing market was valued at USD 4.67 billion in 2019, and is expected to grow at a CAGR of 1.49% during 2019-2025 and at a CAGR of 0.57% during 2025-2035.Japan's animal testing market was valued at USD 1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.51% during 2019-2025, and at a CAGR of 1.73% during 2025-2035.

The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2018 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2019, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.

Non-Animal Testing

The global non-animal alternative testing market was valued at USD 1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025. The USA's non-animal alternative testing technology market was valued at USD 0.336 billion in 2019. The USA's market is forecast to grow at a CAGR of 11.99% through 2025. Japan's non-animal alternative testing technology market was valued at USD 0.058 billion in 2019 and the market is forecast to grow at a CAGR of 6.79% through 2025.

The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2025 post regulatory agencies' validation and approval.

The non-animal alternative testing market trends in the USA and Japan include raising investment for the development of alternatives to animal testing technologies, increasing adoption of in-vitro and in-silico technologies by the pharmaceutical industry, and the use of non-animal testing methods in the cosmetics industry.

The major drivers of the non-animal alternative testing technologies market include technological advances in drug development, ethical concerns on animal experimentations, high costs of animal studies, government programs for non-animal testing, and increasing social awareness against animal cruelty. Factors that could hinder the growth of the non-animal testing include regulatory mandate on animal testing for drug/medical device approval, limitations in in-vitro testing technologies, and a lack of predictive ability of in-vitro testing over in-vivo testing.

The non-animal alternative testing market is fragmented with major developers contributing to around 15-20% of the total market in 2018. Some of the major developers of alternative testing technologies in the USA include Emulate Inc, Organovo Holdings, MatTek Corporation & EMD Millipore. The major Japanese developers include J-TEC, Reprocell Inc. and Organ Technologies.

Comparative Analysis And Regulatory Landscape

Animal tests including genetic toxicity, eye irritation, skin corrosion, skin sensitivity, and others are costlier when compared to non-animal testing technologies. High costs of animal testing include the cost of the animal, and the animal testing operation costs such as maintenance of animals and cost for human resource personnel. Considering all these, the costs for animal testing methods are higher than non-animal alternative testing methods.

In the USA, there are several regulatory agencies including the US Public Health Service, USDA, IACUS, AAALAC, and EPA that are responsible for animal research and welfare. Regulatory agencies for cosmetics have not mandated animal testing in the USA. However, all other industries including pharmaceuticals, medical devices, chemicals, and pesticides require animal testing for new drugs/chemicals before regulatory approval. In Japan, several regulatory agencies including the ministry of environment, MHLW, MEXT, and MAFF are responsible for conducting animal experiments. Companies in Japan are also trying to follow 3R principles from a legal, ethical and scientific point of view.

Alternative Testing Technologies In End Use Industries

Companies in the USA and Japan are developing alternative testing technologies such as cell and tissue culture (in-vitro), organ-on-chip, and in-silico technologies. Cosmetics and bio-pharma industries use these technologies to evaluate toxicity, efficacy, pharmacokinetics, and safety of a drug or a chemical. These technologies vary by the accuracy in drug screening and selection, efficacy, cost and time of the test results. Alternative technologies are widely adopted by cosmetic companies to understand eye irritation, skin irritation and safety studies of chemicals.

The cosmetics segment occupies the major market share in the alternative testing market followed by the medical devices and pharma industries. This is mainly due to the preference of choosing non-animal technologies by cosmetic companies due to several reasons such as potential cost savings, changing attitudes of consumers, and regulatory changes.

There is a need for validated non-animal alternatives for pharma and other end-use industries; hence, the non-animal alternative testing technology developers should focus on getting OECD approval for their developed technologies. The adoption rate of non-animal alternative testing technologies will be high in developed countries compared to emerging nations; hence, non-animal alternative testing technology developers should focus initially on developed markets. These developers should collaborate with animal welfare organizations for better promotion of their products.

READ MORE

Table Of Content

Scope

1. Animal Testing And Non-Animal Alternative Testing Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1.1. Segmentation By Geography

6.1.2. Segmentation By End User Industry

7. Animal Testing And Non-Animal Alternative Testing Market Characteristics

7.1.1. Animal Testing

7.1.2. Non-Animal Alternative Testing

7.1.3. Facts About Animals In Research-Functional Resemblances Of Animals To Human Body

8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis

8.1.1. Animal Breeders and Suppliers

8.1.2. Non-Animal Alternative Testing Technology Developers

8.1.3. Regulatory Authorities

8.1.4. Alternative Testing Service Providers

8.1.5. End-Use Industries

9. Non-Animal Alternative Testing Trends

9.1. Increasing Collaborations & Partnerships To Reduce Animal Testing

9.2. Raising Investments And Research Grants For Developing Alternative Technologies

9.3. Non-Animal Testing Methods In The Cosmetics Industry Are Gaining Traction

10. Cost Analysis For Animal Testing And Alternative Technologies

10.1.1. Average Cost Of Laboratory Animals

10.1.2. Average Cost Of Non-Animal Alternative Testing Methods

10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods

10.2. Costs Involved In Animal Testing, 2018

11. Animal Testing And Non-Animal Alternative Testing Market Segments

11.1. By End Use Industrial Application

11.1.1. Important Areas of Use

11.1.2. End-User Applications

11.2. Animal Testing Market By Animal Type

11.2.1. Mice

11.2.2. Rat

11.2.3. Frogs

11.2.4. Fish

11.2.5. Birds

11.2.6. Guinea pig

11.2.7. Hamster

11.2.8. Rabbits

11.2.9. Sheep

11.2.10. Dogs

11.2.11. Cats

11.2.12. Monkeys

11.2.13. Pigs

11.2.14. Others

12. Number Of Animals Used In Research, By Country

12.1.1. USA

12.1.2. Europe

12.1.3. United Kingdom (UK)

12.1.4. Germany

12.1.5. France

12.1.6. Australia

12.1.7. Canada

12.1.8. China

13. Non-Animal Alternative Testing Technologies By Type And End Use

13.1. Introduction

13.2. Types Of Non-Animal Alternative Testing Technologies

13.2.1. Cell Or Tissue Culture (In-Vitro)

13.2.2. Organ-On-Chip (OOC)

13.2.3. Global OOC Market Size And Growth

13.2.4. Global OOC Market Drivers And Restraints

13.2.5. Market Drivers

13.2.6. Market Restraints

13.2.7. In-silico (Computer-Based Models)

13.2.8. Artificial Skin Models (Skin Substitutes)

13.2.9. Other Technologies

14. End-User Industries Adoption To Alternative Testing Technologies

14.1. Adoption of Alternative Testing Technologies By Type of Industry

14.1.1. Cosmetics Industry

14.1.2. Pharmaceutical Industry

14.1.3. Medical Device Industry

14.1.4. Others

14.2. Adoption of 3R's In USA

14.2.1. 3R Adoption In The Cosmetics Industry

14.2.2. 3R Adoption In The Pharmaceutical Industry

14.2.3. 3R Adoption In The Medical Device Industry

14.3. Adoption of 3R's In China

14.3.1. 3R Adoption In The Cosmetics Industry

14.3.2. 3R Adoption In The Pharmaceutical Industry

14.3.3. 3R Adoption In The Medical Device Industry

14.4. Adoption of 3R's In Europe

14.4.1. 3R Adoption In The Cosmetics Industry

14.4.2. 3R Adoption In The Pharmaceutical Industry

14.4.3. 3R Adoption In The Medical Device Industry

15. Global Animal Testing And Non-Animal Testing Market

15.1. Global Animal Testing Market Size And Growth

15.1.1. Global Animal Testing Market Value (USD Billion)

15.1.2. Global Animal Testing Market, By Volume (Million Units)

15.1.3. Drivers Of The Animal Testing Market

15.1.4. Restraints On The Animal Testing Market

15.2. Global Non-Animal Alternative Testing Market Size And Growth

15.2.1. Global Non-Animal Alternative Testing Market Value (USD Billion)

15.2.2. Drivers Of The Non-Animal Alternative Testing Market

15.2.3. Restraints On The Non-Animal Alternative Testing Market

16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis

17. USA Animal Testing And Non-Animal Alternative Testing Market

17.1. USA Animal Testing Market

17.1.1. USA Animal Testing Market Value (USD Billion)

17.1.2. USA Animal Testing Market, By Volume (Million Units)

17.2. USA Non-Animal Alternative Testing Market

17.2.1. USA Non-Animal Alternative Testing Market Value (USD Billion)

17.3. USA Animal Testing Market By End Use Industrial Application

17.3.1. Market By Value And Volume

17.3.2. Pharmaceuticals

17.3.3. Academic Research industry was the second largest

17.3.4. Medical Devices industry was the third largest

17.3.5. Chemicals And Pesticides industry was the fourth largest

17.3.6. Cosmetics industry was the smallest

17.3.7. Other industries were the fifth largest

17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

17.4. Regulatory Landscape In The USA

17.4.1. Regulatory Bodies & Policies

17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

18. Japan Animal Testing And Non-Animal Alternative Testing Market

18.1. Japan Animal Testing Market

18.1.1. Japan Animal Testing Market Value (USD Billion)

18.1.2. Japan Animal Testing Market, By Volume (Million Units)

18.2. Japan Non-Animal Alternative Testing Market

18.2.1. Japan Non-Animal Alternative Testing Market Value (USD Billion)

18.3. Japan Animal Testing Market By End Use Industrial Application

18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

18.4. Regulatory Landscape In Japan

18.4.1. Regulatory Bodies & Policies

18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

19. China Animal Testing And Non-Animal Alternative Testing Market

19.1. China Animal Testing Market

19.1.1. China Animal Testing Market Value (USD Billion)

19.1.2. China Animal Testing Market, By Volume (Million Units)

19.2. Regulatory Landscape In China

19.2.1. Regulatory Bodies & Policies

19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

20. Australia Animal Testing And Non-Animal Alternative Testing Market

20.1. Australia Animal Testing Market

20.1.1. Australia Animal Testing Market Value (USD Billion)

20.1.2. Australia Animal Testing Market, By Volume (Million Units)

20.2. Regulatory Landscape In Australia

20.2.1. Regulatory Bodies & Policies

20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

21. Europe Animal Testing And Non-Animal Alternative Testing Market

21.1. Regulatory Landscape In Europe

21.1.1. EU Directive 2010/63

21.2. Europe Non-Animal Alternative Testing Market

21.2.1. Europe Non-Animal Alternative Testing Market Value (USD Billion)

22. France Animal Testing And Non-Animal Alternative Testing Market

22.1. France Animal Testing Market

22.1.1. France Animal Testing Market Value (USD Billion)

22.1.2. France Animal Testing Market, By Volume (Million Units)

22.2. France Animal Testing Market By End Use Industrial Application

22.2.1. Market By Value And Volume

22.2.2. Pharmaceuticals

22.2.3. Academic Research industry was the second largest

22.2.4. Chemicals & Pesticides industry was the third largest

22.2.5. Medical Devices industry was the fourth largest

22.2.6. Cosmetics industry was the smallest

22.2.7. Other industries were the fifth largest

22.3. Regulatory Landscape In France

22.3.1. Regulatory Bodies & Policies

22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

23. Germany Animal Testing And Non-Animal Alternative Testing Market

23.1. Germany Animal Testing Market

23.1.1. Germany Animal Testing Market Value (USD Billion)

23.1.2. Germany Animal Testing Market, By Volume (Million Units)

23.2. Germany Animal Testing Market By End Use Industrial Application

23.2.1. Market By Value And Volume

23.2.2. Pharmaceuticals

23.2.3. Academic Research industry was the second largest

23.2.4. Medical Devices industry was the third largest

23.2.5. Chemicals And Pesticides industry was the fifth largest

23.2.6. Cosmetics industry was the smallest

23.2.7. Other industries were the fifth largest

23.3. Regulatory Landscape In Germany

23.3.1. Regulatory Bodies & Policies

23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

24. UK Animal Testing And Non-Animal Alternative Testing Market

24.1. UK Animal Testing Market

24.1.1. UK Animal Testing Market Value (USD Billion)

24.1.2. UK Animal Testing Market, By Volume (Million Units)

24.2. UK Animal Testing Market By End Use Industrial Application

24.2.1. Market By Value And Volume

24.2.2. Pharmaceuticals

24.2.3. Academic Research industry was the second largest

24.2.4. Medical Devices industry was the third largest

24.2.5. Chemicals & Pesticides industry was the fifth largest

24.2.6. Cosmetics industry was the smallest

24.2.7. Other industries were the fourth largest

24.3. Regulatory Landscape in United Kingdom (UK)

24.3.1. Regulatory Bodies & Policies

24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

25. Canada Animal Testing And Non-Animal Alternative Testing Market

25.1. Canada Animal Testing Market

25.1.1. Canada Animal Testing Market Value (USD Billion)

25.1.2. Canada Animal Testing Market, By Volume (Million Units)

25.2. Regulatory Landscape In Canada

25.2.1. Regulatory Bodies & Policies

25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market

26.1. Rest Of The World Animal Testing Market

26.1.1. Rest Of The World Animal Testing Market Value (USD Billion)

26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)

26.2. Rest of The World Non-Animal Alternative Testing Market

26.2.1. Rest of The World Non-Animal Alternative Testing Market Value (USD Billion)

26.3. Regulatory Landscape In Rest of the World (RoW)

26.3.1. Regulatory Bodies & Policies

26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

27. Competitive Landscape For Non-Animal Alternative Technologies

27.1. USA Non-Animal Alternative Testing Market Competitive Landscape

27.1.1. Emulate, Inc

27.1.2. Organovo Holdings, Inc

27.1.3. MatTek Corporation

27.1.4. EMD Millipore

27.2. China Non-Animal Alternative Testing Market Competitive Landscape

27.2.1. China Tissue Engineering Co., Ltd. (J-TEC)

27.2.2. ReproCell Inc

27.2.3. Organ Technologies Co, Ltd

27.3. Europe Non-Animal Alternative Testing Market Competitive Landscape

27.3.1. Episkin

28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies

28.1. Global Animal Testing Market In 2035 Geographies Offering Most New Opportunities

28.2. Global Non-Animal Alternative Testing Market In 2035 Geographies Offering Most New Opportunities

28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 Segments Offering Most New Opportunities

28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2023 Growth Strategies

28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies

28.4.2. Competitor Strategies

29. Conclusions & Recommendations

29.1. Conclusions

29.2. Recommendations

29.2.1. Product

29.2.2. Price

29.2.3. Place

29.2.4. Promotion

29.2.5. People

29.2.6. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries

29.2.7. Increasing Number Of Players In The Non-Animal Alternative Testing Market

29.2.8. Focus On Developed Countries

29.2.9. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion

30. Appendix

30.1. Glossary

30.2. Market Data Sources

30.3. Research Methodology

30.3.1. OCED Accepted In Vito Tests

30.4. Survey on Animal Models & Testing Landscape in the US

30.4.1. Current Condition By Company

30.4.2. Number Of Animals Used In Testing

30.5. Expert Interviews List

30.6. Non Animal Alternative Testing Interviews

30.7. USA Interviews

30.7.1. Interview 1

30.7.2. Interview 2

30.7.3. Interview 3

30.7.4. Interview 4

30.7.5. Interview 5

30.7.6. Interview 6

30.7.7. Interview 7

30.7.8. Interview 8

30.7.9. Interview 9

30.8. China Interviews

30.8.1. Interview 10

30.8.2. Interview 11

30.8.3. Interview 12

30.8.4. Interview 13

30.8.5. Interview 14

30.8.6. Interview 15

30.9. Animal Testing Interviews

30.9.1. Interview 16

30.9.2. Interview 17

30.9.3. Interview 18

30.9.4. Interview 19

30.9.5. Interview 20

30.9.6. Interview 21

30.9.7. Interview 22

31. Interview 23


List Of Figure

Figure 1: Global Animal Testing And Non-Animal Alternative Testing Market Size And Growth Comparison

Figure 2: Global Growth Of Non-Animal Alternative Testing Market By Country

Figure 3: Global Animal Testing Market Segmentation By End User Industry

Figure 4: Value Chain Analysis For Animal Testing & Non-Animal Alternative Testing Market

Figure 5: Statistics of Scientific Procedures on Living Animals in the UK, 2018

Figure 6: Animal Used by Species Group, 2018, (%) (i) Re-use (II) Excludes Re-use

Figure 7: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Figure 8: Global OOC Market, Forecast Market Size, 2019-2023, USD Million

Figure 9: Animal Testing & Non-Animal Alternative Testing Share In The Major End-Use Industries

Figure 10: Global Animal Testing Market Size, 2019-2035, USD Billion

Figure 11: Global Animal Testing Market, Volume, 2019-2035, Million Units

Figure 12: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 13: USA Animal Testing Market Size, 2019-2035, USD Billion

Figure 14: USA Animal Testing Market, Volume, 2019-2035, Million Units

Figure 15: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 16: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019

Figure 17: Japan Animal Testing Market Size, 2019-2035, USD Billion

Figure 18: Japan Animal Testing Market, Volume, 2019-2035, Million Units

Figure 19: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 20: China Animal Testing Market Size, 2019-2035, USD Billion

Figure 21: China Animal Testing Market, Volume, 2019-2035, Million Units

Figure 22: Australia Animal Testing Market Size, 2019-2035, USD Billion

Figure 23: Australia Animal Testing Market, Volume, 2019-2035, Million Units

Figure 24: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 25: France Animal Testing Market Size, 2019-2035, USD Billion

Figure 26: France Animal Testing Market, Volume, 2019-2035, Million Units

Figure 27: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 28: Germany Animal Testing Market Size, 2019-2035, USD Billion

Figure 29: Germany Animal Testing Market, Volume, 2019-2035, Million Units

Figure 30: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 31: UK Animal Testing Market Size, 2019-2035, USD Billion

Figure 32: UK Animal Testing Market, Volume, 2019-2035, Million Units

Figure 33: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 34: Canada Animal Testing Market Size, 2019-2035, USD Billion

Figure 35: Canada Animal Testing Market, Volume, 2019-2035, Million Units

Figure 36: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion

Figure 37: Rest Of The World Animal Testing Market, Volume, 2019-2035, Million Units

Figure 38: Rest of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion


List Of Table

Table 1: Average Cost Of Animals, 2018 (USD )

Table 2: Estimated Cost Analysis For Animal Testing And Non-Animal Alternative Testing Methods, 2018 (USD )

Table 3: Number of Animals Used in Research in the US, 2017

Table 4: Number of Animals Used in Research, UK, 2018

Table 5: Number of Animals Used in Research, Germany, 2018

Table 6: Animal Used by species Group, Germany, (% Share), 2018

Table 7: Number of Animals Used in Research, France, 2017

Table 8: Cell Culture As An Alternative to Animal Testing, Major Cell Culture Developers Worldwide

Table 9: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Table 10: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Table 11: Organ-On-Chips As An Alternative To Animal Testing, Major OOC Developers Worldwide

Table 12: Computer Simulation As An Alternative to Animal Testing, Major In-Silico Model Developers

Table 13: Artificial Skin Model As An Alternative To Animal Testing, Major Artificial Skin Model Developers

Table 14: Non-Animal Alternative Testing Methods Accepted By The US Agencies

Table 15: Non-Animal Alternative Testing Methods Accepted By The China Agencies

Table 16: Non-Animal Alternative Testing Methods Accepted By The European Commission

Table 17: Global Animal Testing Market Size, 2019-2035, USD Billion

Table 18: Global Animal Testing Market, Volume, 2019- 2035, Million Units

Table 19: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 20: USA Animal Testing Market Size, 2019-2035, USD Billion

Table 21: USA Animal Testing Market, Volume, 2019- 2035, Million Units

Table 22: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 23: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019,

Table 24: USA Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018

Table 25: Laboratory Animal Testing Regulatory Landscape In The USA

Table 26: Japan Animal Testing Market Size, 2019-2035, USD Billion

Table 27: Japan Animal Testing Market, Volume, 2019- 2035, Million Units

Table 28: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 29: Japan Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018

Table 30: Laboratory Animal Testing Regulatory Landscape In Japan

Table 31: China Animal Testing Market Size, 2019-2035, USD Billion

Table 32: China Animal Testing Market, Volume, 2019- 2035, Million Units

Table 33: Laboratory Animal Testing Regulatory Landscape In China

Table 34: Australia Animal Testing Market Size, 2019-2035, USD Billion

Table 35: Australia Animal Testing Market, Volume, 2019- 2035, Million Units

Table 36: Laboratory Animal Testing Regulatory Landscape In Australia

Table 37: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 38: France Animal Testing Market Size, 2019-2035, USD Billion

Table 39: France Animal Testing Market, Volume, 2019- 2035, Million Units

Table 40: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 41: Laboratory Animal Testing Regulatory Landscape In France

Table 42: Germany Animal Testing Market Size, 2019-2035, USD Billion

Table 43: Germany Animal Testing Market, Volume, 2019- 2035, Million Units

Table 44: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 45: Laboratory Animal Testing Regulatory Landscape In Germany

Table 46: UK Animal Testing Market Size, 2019-2035, USD Billion

Table 47: UK Animal Testing Market, Volume, 2019- 2035, Million Units

Table 48: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 49: Laboratory Animal Testing Regulatory Landscape In The UK

Table 50: Canada Animal Testing Market Size, 2019-2035, USD Billion

Table 51: Canada Animal Testing Market, Volume, 2019- 2035, Million Units

Table 52: Laboratory Animal Testing Regulatory Landscape In Canada

Table 53: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion

Table 54: Rest Of The World Animal Testing Market, Volume, 2019- 2035, Million Units

Table 55: Rest Of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 56: Laboratory Animal Testing Regulatory Landscape In RoW

Table 57: Emulate Inc, Product Portfolio

Table 58: Emulate Inc, Product & Services

Table 59: Organovo, Product Portfolio

Table 60: MatTek, Product Portfolio

Table 61: EMD Millipore, Product Portfolio

Table 62: J-TEC, Product Portfolio

Table 63: ReproCell, Product Portfolio

Table 64: Organ Technologies Product Portfolio

Table 65: Episkin, Product Portfolio

Table 66: Global Animal Testing Market Size Gain (USD Billion), 2019-2023, By Country

Table 67: Global Non-Animal Alternative Market Size Gain (USD Billion), 2019-2023, By Country

Table 68: Global Animal Testing And Non-Animal Alternative Testing Market Size Gain (USD Billion), Segmentation By Type, 2019-2035

Table 69: Market Data Sources

Table 70: OECD Accepted In-Vitro Tests For Medical Devices

Table 71: Number Of Animals Tested Globally in 2018

Table 72: Expert Interviews List

Licence Rights

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

By Type Of End Use Industrial Application: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Others


Companies

Emulate, Inc.; Organovo Holdings, Inc.; MatTek Corporation; EMD Millipore; China Tissue Engineering Co., Ltd. (J-TEC); ReproCell Inc; Organ Technologies Co, Ltd; Episkin

Company Profile

Company Profile Title

This report describes and evaluates the animal testing and non-alternative testing market in major geographies.

Animal testing or experiment on animals done in the early stages of drug development and for toxicity and safety assessment of medical devices, chemicals, pesticides, cosmetics, and food compounds. Animal experiments are necessary before testing on humans mainly to evaluate toxicity, pharmacokinetics, and safety of a drug or a chemical. However, there is an increasing pressure from the animal welfare organizations on governmental agencies and companies to use non-animal alternative testing technologies. These technologies include in-vitro cell and tissue cultures, organ-on-chip, computer simulations, 3D bio printing of tissues, and synthetic skin substitutes, among others. Industries such as pharmaceuticals, medical devices, chemicals & pesticides and food are increasingly adopting these technologies to replace animal testing.

Animal Testing

The global animal testing market was valued at USD 10.74 billion in 2019and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. USA and Japan are the major animal testing markets in the world.The USA's animal testing market was valued at USD 4.67 billion in 2019, and is expected to grow at a CAGR of 1.49% during 2019-2025 and at a CAGR of 0.57% during 2025-2035.Japan's animal testing market was valued at USD 1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.51% during 2019-2025, and at a CAGR of 1.73% during 2025-2035.

The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2018 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2019, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.

Non-Animal Testing

The global non-animal alternative testing market was valued at USD 1.11 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025. The USA's non-animal alternative testing technology market was valued at USD 0.336 billion in 2019. The USA's market is forecast to grow at a CAGR of 11.99% through 2025. Japan's non-animal alternative testing technology market was valued at USD 0.058 billion in 2019 and the market is forecast to grow at a CAGR of 6.79% through 2025.

The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2025 post regulatory agencies' validation and approval.

The non-animal alternative testing market trends in the USA and Japan include raising investment for the development of alternatives to animal testing technologies, increasing adoption of in-vitro and in-silico technologies by the pharmaceutical industry, and the use of non-animal testing methods in the cosmetics industry.

The major drivers of the non-animal alternative testing technologies market include technological advances in drug development, ethical concerns on animal experimentations, high costs of animal studies, government programs for non-animal testing, and increasing social awareness against animal cruelty. Factors that could hinder the growth of the non-animal testing include regulatory mandate on animal testing for drug/medical device approval, limitations in in-vitro testing technologies, and a lack of predictive ability of in-vitro testing over in-vivo testing.

The non-animal alternative testing market is fragmented with major developers contributing to around 15-20% of the total market in 2018. Some of the major developers of alternative testing technologies in the USA include Emulate Inc, Organovo Holdings, MatTek Corporation & EMD Millipore. The major Japanese developers include J-TEC, Reprocell Inc. and Organ Technologies.

Comparative Analysis And Regulatory Landscape

Animal tests including genetic toxicity, eye irritation, skin corrosion, skin sensitivity, and others are costlier when compared to non-animal testing technologies. High costs of animal testing include the cost of the animal, and the animal testing operation costs such as maintenance of animals and cost for human resource personnel. Considering all these, the costs for animal testing methods are higher than non-animal alternative testing methods.

In the USA, there are several regulatory agencies including the US Public Health Service, USDA, IACUS, AAALAC, and EPA that are responsible for animal research and welfare. Regulatory agencies for cosmetics have not mandated animal testing in the USA. However, all other industries including pharmaceuticals, medical devices, chemicals, and pesticides require animal testing for new drugs/chemicals before regulatory approval. In Japan, several regulatory agencies including the ministry of environment, MHLW, MEXT, and MAFF are responsible for conducting animal experiments. Companies in Japan are also trying to follow 3R principles from a legal, ethical and scientific point of view.

Alternative Testing Technologies In End Use Industries

Companies in the USA and Japan are developing alternative testing technologies such as cell and tissue culture (in-vitro), organ-on-chip, and in-silico technologies. Cosmetics and bio-pharma industries use these technologies to evaluate toxicity, efficacy, pharmacokinetics, and safety of a drug or a chemical. These technologies vary by the accuracy in drug screening and selection, efficacy, cost and time of the test results. Alternative technologies are widely adopted by cosmetic companies to understand eye irritation, skin irritation and safety studies of chemicals.

The cosmetics segment occupies the major market share in the alternative testing market followed by the medical devices and pharma industries. This is mainly due to the preference of choosing non-animal technologies by cosmetic companies due to several reasons such as potential cost savings, changing attitudes of consumers, and regulatory changes.

There is a need for validated non-animal alternatives for pharma and other end-use industries; hence, the non-animal alternative testing technology developers should focus on getting OECD approval for their developed technologies. The adoption rate of non-animal alternative testing technologies will be high in developed countries compared to emerging nations; hence, non-animal alternative testing technology developers should focus initially on developed markets. These developers should collaborate with animal welfare organizations for better promotion of their products.

READ MORE

Scope

1. Animal Testing And Non-Animal Alternative Testing Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

6.1.1. Segmentation By Geography

6.1.2. Segmentation By End User Industry

7. Animal Testing And Non-Animal Alternative Testing Market Characteristics

7.1.1. Animal Testing

7.1.2. Non-Animal Alternative Testing

7.1.3. Facts About Animals In Research-Functional Resemblances Of Animals To Human Body

8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis

8.1.1. Animal Breeders and Suppliers

8.1.2. Non-Animal Alternative Testing Technology Developers

8.1.3. Regulatory Authorities

8.1.4. Alternative Testing Service Providers

8.1.5. End-Use Industries

9. Non-Animal Alternative Testing Trends

9.1. Increasing Collaborations & Partnerships To Reduce Animal Testing

9.2. Raising Investments And Research Grants For Developing Alternative Technologies

9.3. Non-Animal Testing Methods In The Cosmetics Industry Are Gaining Traction

10. Cost Analysis For Animal Testing And Alternative Technologies

10.1.1. Average Cost Of Laboratory Animals

10.1.2. Average Cost Of Non-Animal Alternative Testing Methods

10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods

10.2. Costs Involved In Animal Testing, 2018

11. Animal Testing And Non-Animal Alternative Testing Market Segments

11.1. By End Use Industrial Application

11.1.1. Important Areas of Use

11.1.2. End-User Applications

11.2. Animal Testing Market By Animal Type

11.2.1. Mice

11.2.2. Rat

11.2.3. Frogs

11.2.4. Fish

11.2.5. Birds

11.2.6. Guinea pig

11.2.7. Hamster

11.2.8. Rabbits

11.2.9. Sheep

11.2.10. Dogs

11.2.11. Cats

11.2.12. Monkeys

11.2.13. Pigs

11.2.14. Others

12. Number Of Animals Used In Research, By Country

12.1.1. USA

12.1.2. Europe

12.1.3. United Kingdom (UK)

12.1.4. Germany

12.1.5. France

12.1.6. Australia

12.1.7. Canada

12.1.8. China

13. Non-Animal Alternative Testing Technologies By Type And End Use

13.1. Introduction

13.2. Types Of Non-Animal Alternative Testing Technologies

13.2.1. Cell Or Tissue Culture (In-Vitro)

13.2.2. Organ-On-Chip (OOC)

13.2.3. Global OOC Market Size And Growth

13.2.4. Global OOC Market Drivers And Restraints

13.2.5. Market Drivers

13.2.6. Market Restraints

13.2.7. In-silico (Computer-Based Models)

13.2.8. Artificial Skin Models (Skin Substitutes)

13.2.9. Other Technologies

14. End-User Industries Adoption To Alternative Testing Technologies

14.1. Adoption of Alternative Testing Technologies By Type of Industry

14.1.1. Cosmetics Industry

14.1.2. Pharmaceutical Industry

14.1.3. Medical Device Industry

14.1.4. Others

14.2. Adoption of 3R's In USA

14.2.1. 3R Adoption In The Cosmetics Industry

14.2.2. 3R Adoption In The Pharmaceutical Industry

14.2.3. 3R Adoption In The Medical Device Industry

14.3. Adoption of 3R's In China

14.3.1. 3R Adoption In The Cosmetics Industry

14.3.2. 3R Adoption In The Pharmaceutical Industry

14.3.3. 3R Adoption In The Medical Device Industry

14.4. Adoption of 3R's In Europe

14.4.1. 3R Adoption In The Cosmetics Industry

14.4.2. 3R Adoption In The Pharmaceutical Industry

14.4.3. 3R Adoption In The Medical Device Industry

15. Global Animal Testing And Non-Animal Testing Market

15.1. Global Animal Testing Market Size And Growth

15.1.1. Global Animal Testing Market Value (USD Billion)

15.1.2. Global Animal Testing Market, By Volume (Million Units)

15.1.3. Drivers Of The Animal Testing Market

15.1.4. Restraints On The Animal Testing Market

15.2. Global Non-Animal Alternative Testing Market Size And Growth

15.2.1. Global Non-Animal Alternative Testing Market Value (USD Billion)

15.2.2. Drivers Of The Non-Animal Alternative Testing Market

15.2.3. Restraints On The Non-Animal Alternative Testing Market

16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis

17. USA Animal Testing And Non-Animal Alternative Testing Market

17.1. USA Animal Testing Market

17.1.1. USA Animal Testing Market Value (USD Billion)

17.1.2. USA Animal Testing Market, By Volume (Million Units)

17.2. USA Non-Animal Alternative Testing Market

17.2.1. USA Non-Animal Alternative Testing Market Value (USD Billion)

17.3. USA Animal Testing Market By End Use Industrial Application

17.3.1. Market By Value And Volume

17.3.2. Pharmaceuticals

17.3.3. Academic Research industry was the second largest

17.3.4. Medical Devices industry was the third largest

17.3.5. Chemicals And Pesticides industry was the fourth largest

17.3.6. Cosmetics industry was the smallest

17.3.7. Other industries were the fifth largest

17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

17.4. Regulatory Landscape In The USA

17.4.1. Regulatory Bodies & Policies

17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

18. Japan Animal Testing And Non-Animal Alternative Testing Market

18.1. Japan Animal Testing Market

18.1.1. Japan Animal Testing Market Value (USD Billion)

18.1.2. Japan Animal Testing Market, By Volume (Million Units)

18.2. Japan Non-Animal Alternative Testing Market

18.2.1. Japan Non-Animal Alternative Testing Market Value (USD Billion)

18.3. Japan Animal Testing Market By End Use Industrial Application

18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)

18.4. Regulatory Landscape In Japan

18.4.1. Regulatory Bodies & Policies

18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

19. China Animal Testing And Non-Animal Alternative Testing Market

19.1. China Animal Testing Market

19.1.1. China Animal Testing Market Value (USD Billion)

19.1.2. China Animal Testing Market, By Volume (Million Units)

19.2. Regulatory Landscape In China

19.2.1. Regulatory Bodies & Policies

19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

20. Australia Animal Testing And Non-Animal Alternative Testing Market

20.1. Australia Animal Testing Market

20.1.1. Australia Animal Testing Market Value (USD Billion)

20.1.2. Australia Animal Testing Market, By Volume (Million Units)

20.2. Regulatory Landscape In Australia

20.2.1. Regulatory Bodies & Policies

20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

21. Europe Animal Testing And Non-Animal Alternative Testing Market

21.1. Regulatory Landscape In Europe

21.1.1. EU Directive 2010/63

21.2. Europe Non-Animal Alternative Testing Market

21.2.1. Europe Non-Animal Alternative Testing Market Value (USD Billion)

22. France Animal Testing And Non-Animal Alternative Testing Market

22.1. France Animal Testing Market

22.1.1. France Animal Testing Market Value (USD Billion)

22.1.2. France Animal Testing Market, By Volume (Million Units)

22.2. France Animal Testing Market By End Use Industrial Application

22.2.1. Market By Value And Volume

22.2.2. Pharmaceuticals

22.2.3. Academic Research industry was the second largest

22.2.4. Chemicals & Pesticides industry was the third largest

22.2.5. Medical Devices industry was the fourth largest

22.2.6. Cosmetics industry was the smallest

22.2.7. Other industries were the fifth largest

22.3. Regulatory Landscape In France

22.3.1. Regulatory Bodies & Policies

22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market

23. Germany Animal Testing And Non-Animal Alternative Testing Market

23.1. Germany Animal Testing Market

23.1.1. Germany Animal Testing Market Value (USD Billion)

23.1.2. Germany Animal Testing Market, By Volume (Million Units)

23.2. Germany Animal Testing Market By End Use Industrial Application

23.2.1. Market By Value And Volume

23.2.2. Pharmaceuticals

23.2.3. Academic Research industry was the second largest

23.2.4. Medical Devices industry was the third largest

23.2.5. Chemicals And Pesticides industry was the fifth largest

23.2.6. Cosmetics industry was the smallest

23.2.7. Other industries were the fifth largest

23.3. Regulatory Landscape In Germany

23.3.1. Regulatory Bodies & Policies

23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

24. UK Animal Testing And Non-Animal Alternative Testing Market

24.1. UK Animal Testing Market

24.1.1. UK Animal Testing Market Value (USD Billion)

24.1.2. UK Animal Testing Market, By Volume (Million Units)

24.2. UK Animal Testing Market By End Use Industrial Application

24.2.1. Market By Value And Volume

24.2.2. Pharmaceuticals

24.2.3. Academic Research industry was the second largest

24.2.4. Medical Devices industry was the third largest

24.2.5. Chemicals & Pesticides industry was the fifth largest

24.2.6. Cosmetics industry was the smallest

24.2.7. Other industries were the fourth largest

24.3. Regulatory Landscape in United Kingdom (UK)

24.3.1. Regulatory Bodies & Policies

24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market

25. Canada Animal Testing And Non-Animal Alternative Testing Market

25.1. Canada Animal Testing Market

25.1.1. Canada Animal Testing Market Value (USD Billion)

25.1.2. Canada Animal Testing Market, By Volume (Million Units)

25.2. Regulatory Landscape In Canada

25.2.1. Regulatory Bodies & Policies

25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market

26.1. Rest Of The World Animal Testing Market

26.1.1. Rest Of The World Animal Testing Market Value (USD Billion)

26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)

26.2. Rest of The World Non-Animal Alternative Testing Market

26.2.1. Rest of The World Non-Animal Alternative Testing Market Value (USD Billion)

26.3. Regulatory Landscape In Rest of the World (RoW)

26.3.1. Regulatory Bodies & Policies

26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market

27. Competitive Landscape For Non-Animal Alternative Technologies

27.1. USA Non-Animal Alternative Testing Market Competitive Landscape

27.1.1. Emulate, Inc

27.1.2. Organovo Holdings, Inc

27.1.3. MatTek Corporation

27.1.4. EMD Millipore

27.2. China Non-Animal Alternative Testing Market Competitive Landscape

27.2.1. China Tissue Engineering Co., Ltd. (J-TEC)

27.2.2. ReproCell Inc

27.2.3. Organ Technologies Co, Ltd

27.3. Europe Non-Animal Alternative Testing Market Competitive Landscape

27.3.1. Episkin

28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies

28.1. Global Animal Testing Market In 2035 Geographies Offering Most New Opportunities

28.2. Global Non-Animal Alternative Testing Market In 2035 Geographies Offering Most New Opportunities

28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 Segments Offering Most New Opportunities

28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2023 Growth Strategies

28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies

28.4.2. Competitor Strategies

29. Conclusions & Recommendations

29.1. Conclusions

29.2. Recommendations

29.2.1. Product

29.2.2. Price

29.2.3. Place

29.2.4. Promotion

29.2.5. People

29.2.6. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries

29.2.7. Increasing Number Of Players In The Non-Animal Alternative Testing Market

29.2.8. Focus On Developed Countries

29.2.9. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion

30. Appendix

30.1. Glossary

30.2. Market Data Sources

30.3. Research Methodology

30.3.1. OCED Accepted In Vito Tests

30.4. Survey on Animal Models & Testing Landscape in the US

30.4.1. Current Condition By Company

30.4.2. Number Of Animals Used In Testing

30.5. Expert Interviews List

30.6. Non Animal Alternative Testing Interviews

30.7. USA Interviews

30.7.1. Interview 1

30.7.2. Interview 2

30.7.3. Interview 3

30.7.4. Interview 4

30.7.5. Interview 5

30.7.6. Interview 6

30.7.7. Interview 7

30.7.8. Interview 8

30.7.9. Interview 9

30.8. China Interviews

30.8.1. Interview 10

30.8.2. Interview 11

30.8.3. Interview 12

30.8.4. Interview 13

30.8.5. Interview 14

30.8.6. Interview 15

30.9. Animal Testing Interviews

30.9.1. Interview 16

30.9.2. Interview 17

30.9.3. Interview 18

30.9.4. Interview 19

30.9.5. Interview 20

30.9.6. Interview 21

30.9.7. Interview 22

31. Interview 23


List Of Figure

Figure 1: Global Animal Testing And Non-Animal Alternative Testing Market Size And Growth Comparison

Figure 2: Global Growth Of Non-Animal Alternative Testing Market By Country

Figure 3: Global Animal Testing Market Segmentation By End User Industry

Figure 4: Value Chain Analysis For Animal Testing & Non-Animal Alternative Testing Market

Figure 5: Statistics of Scientific Procedures on Living Animals in the UK, 2018

Figure 6: Animal Used by Species Group, 2018, (%) (i) Re-use (II) Excludes Re-use

Figure 7: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Figure 8: Global OOC Market, Forecast Market Size, 2019-2023, USD Million

Figure 9: Animal Testing & Non-Animal Alternative Testing Share In The Major End-Use Industries

Figure 10: Global Animal Testing Market Size, 2019-2035, USD Billion

Figure 11: Global Animal Testing Market, Volume, 2019-2035, Million Units

Figure 12: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 13: USA Animal Testing Market Size, 2019-2035, USD Billion

Figure 14: USA Animal Testing Market, Volume, 2019-2035, Million Units

Figure 15: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 16: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019

Figure 17: Japan Animal Testing Market Size, 2019-2035, USD Billion

Figure 18: Japan Animal Testing Market, Volume, 2019-2035, Million Units

Figure 19: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 20: China Animal Testing Market Size, 2019-2035, USD Billion

Figure 21: China Animal Testing Market, Volume, 2019-2035, Million Units

Figure 22: Australia Animal Testing Market Size, 2019-2035, USD Billion

Figure 23: Australia Animal Testing Market, Volume, 2019-2035, Million Units

Figure 24: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Figure 25: France Animal Testing Market Size, 2019-2035, USD Billion

Figure 26: France Animal Testing Market, Volume, 2019-2035, Million Units

Figure 27: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 28: Germany Animal Testing Market Size, 2019-2035, USD Billion

Figure 29: Germany Animal Testing Market, Volume, 2019-2035, Million Units

Figure 30: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 31: UK Animal Testing Market Size, 2019-2035, USD Billion

Figure 32: UK Animal Testing Market, Volume, 2019-2035, Million Units

Figure 33: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Figure 34: Canada Animal Testing Market Size, 2019-2035, USD Billion

Figure 35: Canada Animal Testing Market, Volume, 2019-2035, Million Units

Figure 36: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion

Figure 37: Rest Of The World Animal Testing Market, Volume, 2019-2035, Million Units

Figure 38: Rest of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion


List Of Table

Table 1: Average Cost Of Animals, 2018 (USD )

Table 2: Estimated Cost Analysis For Animal Testing And Non-Animal Alternative Testing Methods, 2018 (USD )

Table 3: Number of Animals Used in Research in the US, 2017

Table 4: Number of Animals Used in Research, UK, 2018

Table 5: Number of Animals Used in Research, Germany, 2018

Table 6: Animal Used by species Group, Germany, (% Share), 2018

Table 7: Number of Animals Used in Research, France, 2017

Table 8: Cell Culture As An Alternative to Animal Testing, Major Cell Culture Developers Worldwide

Table 9: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Table 10: Global OOC Market, Historic Market Size, 2015-2019, USD Million

Table 11: Organ-On-Chips As An Alternative To Animal Testing, Major OOC Developers Worldwide

Table 12: Computer Simulation As An Alternative to Animal Testing, Major In-Silico Model Developers

Table 13: Artificial Skin Model As An Alternative To Animal Testing, Major Artificial Skin Model Developers

Table 14: Non-Animal Alternative Testing Methods Accepted By The US Agencies

Table 15: Non-Animal Alternative Testing Methods Accepted By The China Agencies

Table 16: Non-Animal Alternative Testing Methods Accepted By The European Commission

Table 17: Global Animal Testing Market Size, 2019-2035, USD Billion

Table 18: Global Animal Testing Market, Volume, 2019- 2035, Million Units

Table 19: Global Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 20: USA Animal Testing Market Size, 2019-2035, USD Billion

Table 21: USA Animal Testing Market, Volume, 2019- 2035, Million Units

Table 22: USA Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 23: USA Animal Testing Market, By End Use Industrial Application, By Value (USD Billion), And By Volume (Millions) 2019,

Table 24: USA Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018

Table 25: Laboratory Animal Testing Regulatory Landscape In The USA

Table 26: Japan Animal Testing Market Size, 2019-2035, USD Billion

Table 27: Japan Animal Testing Market, Volume, 2019- 2035, Million Units

Table 28: Japan Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 29: Japan Animal Testing Market, Share of Top 5 Companies (In Each Industrial Application), 2018

Table 30: Laboratory Animal Testing Regulatory Landscape In Japan

Table 31: China Animal Testing Market Size, 2019-2035, USD Billion

Table 32: China Animal Testing Market, Volume, 2019- 2035, Million Units

Table 33: Laboratory Animal Testing Regulatory Landscape In China

Table 34: Australia Animal Testing Market Size, 2019-2035, USD Billion

Table 35: Australia Animal Testing Market, Volume, 2019- 2035, Million Units

Table 36: Laboratory Animal Testing Regulatory Landscape In Australia

Table 37: Europe Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 38: France Animal Testing Market Size, 2019-2035, USD Billion

Table 39: France Animal Testing Market, Volume, 2019- 2035, Million Units

Table 40: France Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 41: Laboratory Animal Testing Regulatory Landscape In France

Table 42: Germany Animal Testing Market Size, 2019-2035, USD Billion

Table 43: Germany Animal Testing Market, Volume, 2019- 2035, Million Units

Table 44: Germany Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 45: Laboratory Animal Testing Regulatory Landscape In Germany

Table 46: UK Animal Testing Market Size, 2019-2035, USD Billion

Table 47: UK Animal Testing Market, Volume, 2019- 2035, Million Units

Table 48: UK Animal Testing Market, By End Use Industrial Application, By Value, 2019, USD Billion

Table 49: Laboratory Animal Testing Regulatory Landscape In The UK

Table 50: Canada Animal Testing Market Size, 2019-2035, USD Billion

Table 51: Canada Animal Testing Market, Volume, 2019- 2035, Million Units

Table 52: Laboratory Animal Testing Regulatory Landscape In Canada

Table 53: Rest Of The World Animal Testing Market Size, 2019-2035, USD Billion

Table 54: Rest Of The World Animal Testing Market, Volume, 2019- 2035, Million Units

Table 55: Rest Of The World Non-Animal Alternative Testing Market Size, 2019-2035, USD Billion

Table 56: Laboratory Animal Testing Regulatory Landscape In RoW

Table 57: Emulate Inc, Product Portfolio

Table 58: Emulate Inc, Product & Services

Table 59: Organovo, Product Portfolio

Table 60: MatTek, Product Portfolio

Table 61: EMD Millipore, Product Portfolio

Table 62: J-TEC, Product Portfolio

Table 63: ReproCell, Product Portfolio

Table 64: Organ Technologies Product Portfolio

Table 65: Episkin, Product Portfolio

Table 66: Global Animal Testing Market Size Gain (USD Billion), 2019-2023, By Country

Table 67: Global Non-Animal Alternative Market Size Gain (USD Billion), 2019-2023, By Country

Table 68: Global Animal Testing And Non-Animal Alternative Testing Market Size Gain (USD Billion), Segmentation By Type, 2019-2035

Table 69: Market Data Sources

Table 70: OECD Accepted In-Vitro Tests For Medical Devices

Table 71: Number Of Animals Tested Globally in 2018

Table 72: Expert Interviews List

  • Single User License (for access by one person)
  • Site License (for access of one office location of a company)
  • Corporate License (allow access by all staff of the company)
To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

By Type Of End Use Industrial Application: Pharmaceuticals; Academic Research; Medical Devices; Chemicals & Pesticides; Cosmetics; Others


Companies

Emulate, Inc.; Organovo Holdings, Inc.; MatTek Corporation; EMD Millipore; China Tissue Engineering Co., Ltd. (J-TEC); ReproCell Inc; Organ Technologies Co, Ltd; Episkin